Form 10-Q CANCER GENETICS, INC For: Mar 31

Go back to Form 10-Q CANCER GENETICS, INC For: Mar 31

Cancer Genetics (CGIX) Tops Q1 EPS by 10c

May 12, 2015 7:32 AM EDT

Cancer Genetics (NASDAQ: CGIX) reported Q1 EPS of ($0.44), $0.10 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $3.91 million.

For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.

... More